Clinical Studies

Whole food ingredients are where every Oceanutra formula starts — but they’re not where it stops. Before an ingredient earns a place in one of our products, we look past how it sounds on a label and into what published, peer-reviewed research actually shows it does in the body. That’s how a wholesome ingredient becomes an effective one: real sourcing, paired with real science. We don’t ask you to take our word for it — the studies below are the same research our formulation decisions are built on, so you can see exactly why each ingredient is there.

DATE ▲ ▼
TITLE
Jul 01, 2026
Jul 01, 2026(Loukil, Jul 2026): Krill oil raised blood omega-3 levels further than the same dose of fish oil — supporting proper heart health.Loukil, I., Vachon, A., Çaku, A., & Plourde, M. (2026). Krill oil increases plasma omega-3 fatty acids more than fish oil in healthy adults: a double-blind randomized controlled trial. American Journal of Clinical Nutrition, 124(1), 101346.

A direct head-to-head trial (72 adults, ~1.1g/day omega-3s — matching Oceanutra's serving) found krill oil raised blood EPA levels 1.4x more and DHA levels 1.5x more than an equal dose of fish oil. Strongest available "krill outperforms fish oil" data point.

Read Study ↗
Jan 27, 2025
Jan 27, 2025(Tabassum, Jan 2025): Astaxanthin, krill oil’s natural antioxidant, eased knee pain — contributing to proper joint function.Tabassum, M., Rahman, M. S., Ahmed, S. M., Chowdhury, I. H., Huda, S. M. N., Sultana, S., Aktar, S., Marnush, M., & Jalil, M. A. (2025). Potential of astaxanthin in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Journal of Orthopaedics and Sports Medicine, 7(1), 23–32.

In a placebo-controlled trial, 12mg/day of astaxanthin — the same antioxidant naturally found in krill oil (not present in standard fish oil) — significantly improved knee pain and physical function scores and reduced inflammatory markers (hsCRP, IL-6) over 8 weeks.

Read Study ↗
Feb 14, 2025
Feb 14, 2025(Meng, Feb 2025): Krill oil eased knee pain, stiffness and improved function — contributing to proper joint function.Meng, J., Wang, X., Li, Y. H., Xiang, Y., Wu, Y., Xiong, Y., Liu, P., & Gao, S. (2025). Krill oil for knee osteoarthritis: a meta-analysis of randomized controlled trials. Medicine, 104(7), e41566.

A meta-analysis of randomized controlled trials found krill oil supplementation improved WOMAC pain, stiffness, and function scores in people with knee osteoarthritis — the strongest positive, krill-oil-specific joint evidence currently available.

Read Study ↗
Aug 20, 2025
Aug 20, 2025(Shahinfar, Aug 2025): Omega-3s improved attention, memory and overall cognitive ability — helping maintain proper cognitive function.Shahinfar, H., Yazdian, Z., Asgari Avini, N., Torabinasab, K., & Shab-Bidar, S. (2025). A systematic review and dose response meta-analysis of omega-3 supplementation on cognitive function. Scientific Reports, 15(1), 30610.

A dose-response meta-analysis of 58 clinical trials found omega-3 supplementation produced measurable improvements in attention, language, memory, and overall cognitive ability, with benefits scaling with dose up to an optimal threshold.

Read Study ↗
Dec 02, 2025
Dec 02, 2025(Dias, Dec 2025): Omega-3s support lean muscle mass during GLP-1-driven weight loss.Dias, D. D., Vasconcelos, A. R., Souza, A. C. R., de Menezes, C., Teixeira e Silva, I. S., & Name, J. J. (2025). Nutritional approaches to enhance GLP-1 analogue therapy in obesity: a narrative review. Obesities, 5(4), 88.

This review identifies omega-3 fatty acids as a supportive nutritional adjunct for people on GLP-1 medications — supporting the anti-inflammatory pathways involved and helping protect lean muscle mass during GLP-1-driven weight loss. (Review article, not a standalone trial — frame as "supports the pathways GLP-1 relies on," not "boosts GLP-1.")

Read Study ↗
May 24, 2023
May 24, 2023(Deng, May 2023): Omega-3s relieved arthritis pain and improved joint function — contributing to proper joint function.Deng, W., Yi, Z., Yin, E., Lu, R., You, H., & Yuan, X. (2023). Effect of omega-3 polyunsaturated fatty acids supplementation for patients with osteoarthritis: a meta-analysis. Journal of Orthopaedic Surgery and Research, 18(1), 381.

A meta-analysis of 9 randomized trials and 2,070 osteoarthritis patients found omega-3 supplementation significantly relieved arthritis pain and improved joint function, with no serious adverse events reported.

Read Study ↗
: Jan 01, 2022
: Jan 01, 2022(Welty, 2022): High-dose EPA and DHA slowed cognitive aging by 2.5 years — helping maintain proper cognitive function.Welty, F. K. (2022). Omega-3 fatty acids and cognitive function. Current Opinion in Lipidology, 34(1), 12–21.

In cognitively healthy people with coronary artery disease, 3.36g/day EPA+DHA slowed cognitive aging by approximately 2.5 years. Higher DHA intake was also linked to lower dementia risk (RR 0.86) and lower Alzheimer's risk (RR 0.63).

Read Study ↗
Mar 25, 2022
Mar 25, 2022(Mone, Mar 2022): Omega-3s lowered insulin and triglycerides and triggered the body’s own GLP-1 release — supporting proper metabolic function.Mone, P., Varzideh, F., Kansakar, U., Infante, C., Lombardi, A., de Donato, A., Frullone, S., & Santulli, G. (2022). Omega-3 fatty acids coordinate glucose and lipid metabolism in diabetic patients. Lipids in Health and Disease, 21, 31.

Reviewing a 150-patient randomized trial, this paper shows omega-3 fatty acids significantly reduced insulin and triglyceride levels in people with type 2 diabetes, and explains the receptor pathway (GPR120) by which omega-3s trigger the release of GLP-1 in the gut.

Read Study ↗
Nov 10, 2018
Nov 10, 2018(Bhatt, Nov 2018): High-dose EPA cut major cardiovascular events in at-risk patients — supporting proper heart health.Bhatt, D. L., Steg, P. G., Miller, M., et al. (2019). Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. New England Journal of Medicine, 380(1), 11–22.

8,179 statin-treated patients with elevated triglycerides received 4g/day icosapent ethyl (a purified, prescription EPA) or placebo over a median of 4.9 years. Found a 25% relative risk reduction in major cardiovascular events — one of the largest omega-3 outcome trials on record.

Read Study ↗
Nov 04, 2015
Nov 04, 2015(Ramprasath, Nov 2015): Higher phospholipid concentration meant deeper omega-3 absorption — supporting proper heart health.Ramprasath, V. R., Eyal, I., Zchut, S., Shafat, I., & Jones, P. J. H. (2015). Supplementation of krill oil with high phospholipid content increases sum of EPA and DHA in erythrocytes compared with low phospholipid krill oil. Lipids in Health and Disease, 14, 142.

Comparing two krill oil formulations, the higher-phospholipid version (56% vs. ~40% industry-standard) significantly increased red-blood-cell EPA+DHA more than the lower-phospholipid version — direct support for phospholipid concentration itself driving absorption. Note: doses tested (1.5g low-phospholipid vs. 3g high-phospholipid) don't match Oceanutra's 1g labeled serving — cite as supporting mechanism evidence, not an at-dose guarantee (see flag #2).

Read Study ↗
May 14, 2014
May 14, 2014(Nguyen, May 2014): Found why krill’s phospholipid-bound DHA crosses into the brain — the mechanism behind proper cognitive function.Nguyen, L. N., Ma, D., Shui, G., Wong, P., Cazenave-Gassiot, A., Zhang, X., Wenk, M. R., Goh, E. L. K., & Silver, D. L. (2014). Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature, 509(7501), 503–506.

Identified the Mfsd2a transporter as the mechanism that lets DHA cross the blood-brain barrier — and found it only recognizes DHA in phospholipid form, not the triglyceride form standard fish oil delivers. This is the underlying science behind why krill's phospholipid-bound omega-3s can reach brain tissue in a way fish oil's can't. Foundational molecular biology (mouse model), not a human supplementation trial — pair with Konagai above rather than presenting as a standalone "study found X% improvement" claim.

Read Study ↗
Sep 19, 2013
Sep 19, 2013(Konagai, Sep 2013): Krill oil supported memory and mental sharpness in older adults — helping maintain proper cognitive function.Konagai, C., Yanagimoto, K., Hayamizu, K., Han, L., Tsuji, T., & Koga, Y. (2013). Effects of krill oil containing n-3 polyunsaturated fatty acids in phospholipid form on human brain function: a randomized controlled trial in healthy elderly volunteers. Clinical Interventions in Aging, 8, 1247–1257.

In healthy elderly volunteers, krill oil significantly improved brain activation during memory and calculation tasks and improved a marker of cognitive processing speed — outperforming a comparable dose of sardine (fish) oil on 2 of 3 measures, despite delivering less total EPA/DHA.

Read Study ↗
Dec 18, 2013
Dec 18, 2013(Berge, Dec 2013): Krill oil lowered triglycerides without raising LDL cholesterol — supporting proper heart health.Berge, K., Musa-Veloso, K., Harwood, M., Hoem, N., & Burri, L. (2014). Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels. Nutrition Research, 34(2), 126–133.

A 300-person, double-blind, placebo-controlled, multi-center
trial testing krill oil at 0.5–4g/day (including a 1g/day arm matching
Oceanutra's serving size) found it lowered triglycerides without raising LDL
cholesterol — a specific advantage over some fish oil trials, which can raise
LDL.

Read Study ↗
Jan 01, 2011
Jan 01, 2011(Schuchardt, 2011): Krill oil’s phospholipid form absorbed better than fish oil — supporting proper heart health.Schuchardt, J. P., Schneider, I., Meyer, H., Neubronner, J., von Schacky, C., & Hahn, A. (2011). Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations—a comparative bioavailability study of fish oil vs. krill oil. Lipids in Health and Disease, 10, 145.

A crossover trial in 12 healthy men found krill oil produced the highest incorporation of EPA+DHA into plasma phospholipids (80.03%·h), beating both re-esterified fish oil triglycerides (59.78%·h) and fish oil ethyl esters (47.53%·h) — a head-to-head win over fish oil.

Read Study ↗
Jan 01, 2007
Jan 01, 2007(Deutsch, 2007): Krill oil lowered inflammation and eased joint pain and stiffness — contributing to proper joint function.Deutsch, L. (2007). Evaluation of the effect of Neptune Krill Oil on chronic inflammation and arthritic symptoms. Journal of the American College of Nutrition, 26(1), 39–48.

90 patients with cardiovascular disease and/or arthritis and elevated CRP were randomized to 300mg/day Neptune Krill Oil or placebo for 30 days. Krill oil reduced CRP by 31.1% (vs. a 12.5% increase in placebo) and cut WOMAC pain score by 28.9%, stiffness by 20.3%, and functional impairment by 22.8%.

Read Study ↗
Jan 01, 2007
Jan 01, 2007(Goldberg & Katz, 2007): Omega-3s reduced joint pain, morning stiffness and reliance on pain medication — contributing to proper joint function.Goldberg, R. J., & Katz, J. (2007). A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain, 129(1-2), 210–223.

A meta-analysis of 17 randomized trials found omega-3 supplementation for 3–4 months significantly reduced patient-reported joint pain intensity, morning stiffness, and NSAID/painkiller use in rheumatoid arthritis and inflammatory bowel disease patients.

Read Study ↗
Mar 31, 2007
Mar 31, 2007(Yokoyama/JELIS, Mar 2007): EPA reduced major coronary events on top of statin therapy — supporting proper heart health.Yokoyama, M., Origasa, H., Matsuzaki, M., et al. (2007). Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet, 369(9567), 1090–1098.

18,645 Japanese adults with high cholesterol, already on statins, were randomized to 1.8g/day EPA or usual care. EPA produced a 19% relative risk reduction in major coronary events over 4.6 years — added evidence on top of a statin, not instead of one.

Read Study ↗